GlassScriptPhysician profile
Fabio Komlos
NPI 1710147061
$19,130.33
in general payments reported to CMS, 2019-2025
22 companies · $1,430 in 2025
The $1,430 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,980 · 2020: $580 · 2021: $1,732 · 2022: $2,589 · 2023: $3,705 · 2024: $2,115 · 2025: $1,430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,763 · Food and Beverage: $2,886 · Consulting Fee: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,763.10 |
| Food and Beverage | $2,885.99 |
| Consulting Fee | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $6,228.07 | 2019-2023 | |
| Boston Scientific Corporation | $6,033.00 | 2021-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Varithena Administration Pack, Angiojet Ultra 5000a |
| W. L. Gore & Associates, INC. | $1,223.61 | 2022-2023 | Gore Tag Thoracic Endoprosthesis |
| Histosonics, INC. | $1,007.40 | 2025 | |
| Inari Medical, INC. | $967.40 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shockwave Medical, INC | $766.83 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inquis Medical, INC. | $576.68 | 2024-2025 | Aventus |
| Argon Medical Devices, INC. | $472.38 | 2019-2025 | Clot Management |
| Abbott Laboratories | $467.53 | 2019-2024 | Amplatzer Amulet |
| Bard Peripheral Vascular, INC. | $388.49 | 2019-2020 | |
| Penumbra, INC. | $312.71 | 2022-2024 | Penumbra System, Indigo System |
| Nevro Corp. | $193.76 | 2019-2022 | |
| Trisalus Life Sciences, INC. | $119.12 | 2024 | Trinav Infusion System |
| Endologix LLC | $93.57 | 2023 | |
| Angiodynamics, INC. | $77.66 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $48.66 | 2019-2024 | Lava Les (Liquid Embolic System) |
| Medtronic USA, INC. | $42.11 | 2019 | |
| Cook Medical LLC | $27.84 | 2023 | Rosch-Uchida |
| Rigel Pharmaceuticals, INC. | $25.64 | 2019 | |
| Janssen Biotech, INC. | $23.99 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.00 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,565.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fabio Komlos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.